Back to Search Start Over

Physiotherapist-led exercise versus usual care (waiting-list) control for patients awaiting rotator cuff repair surgery: A pilot randomised controlled trial (POWER).

Authors :
Littlewood C
Moffatt M
Beckhelling J
Davis D
Burden A
Pitt L
Lalande S
Maddocks C
Stephens G
Tunnicliffe H
Pawson J
Lloyd J
Manca A
Wade J
Foster NE
Source :
Musculoskeletal science & practice [Musculoskelet Sci Pract] 2023 Nov; Vol. 68, pp. 102874. Date of Electronic Publication: 2023 Oct 30.
Publication Year :
2023

Abstract

Background: Once a decision to undergo rotator cuff repair surgery is made, patients are placed on the waiting list. It can take weeks or months to receive surgery. There has been a call to move from waiting lists to 'preparation' lists to better prepare patients for surgery and to ensure it remains an appropriate treatment option for them.<br />Objective: To evaluate the feasibility, as measured by recruitment rates, treatment fidelity and follow-up rates, of a future multi-centre randomised controlled trial to compare the clinical and cost-effectiveness of undertaking a physiotherapist-led exercise programme while waiting for surgery versus usual care (waiting-list control).<br />Design: Two-arm, multi-centre pilot randomised controlled trial with feasibility objectives in six NHS hospitals in England.<br />Method: Adults (n = 76) awaiting rotator cuff repair surgery were recruited and randomly allocated to a programme of physiotherapist-led exercise (n = 38) or usual care control (n = 38).<br />Results: Of 302 eligible patients, 76 (25%) were randomised. Of 38 participants randomised to physiotherapist-led exercise, 28 (74%) received the exercise programme as intended. 51/76 (67%) Shoulder Pain and Disability Index questionnaires were returned at 6-months. Of 76 participants, 32 had not received surgery after 6-months (42%). Of those 32, 20 were allocated to physiotherapist-led exercise; 12 to usual care control.<br />Conclusions: A future multi-centre randomised controlled trial is feasible but would require planning for variable recruitment rates between sites, measures to improve treatment fidelity and opportunity for surgical exit, and optimisation of follow-up. A fully powered, randomised controlled trial is now needed to robustly inform clinical decision-making.<br /> (Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.)

Details

Language :
English
ISSN :
2468-7812
Volume :
68
Database :
MEDLINE
Journal :
Musculoskeletal science & practice
Publication Type :
Academic Journal
Accession number :
37926065
Full Text :
https://doi.org/10.1016/j.msksp.2023.102874